Delivery Order SPE2DB20D2014-SPE2DB25FA29W

Award Date 11/7/24
Potential Completion Date 11/8/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VALTOCO 10 MG NASAL SPRAYS to the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of the prime contractor Amerisourcebergen Drug Corp Corporate Office Division. The contract, valued at $1,253.65, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a...
This federal contract award is for the delivery of VALTOCO 10 MG NASAL SPRAYS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,355.52 and a completion date of February 18, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for the delivery of VALTOCO 10 MG NASAL SPRAYS to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,355.52 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the supply of VALTOCO 10 MG NASAL SPRAYS to the Defense Logistics Agency (DLA), a defense agency. The $2,266.94 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has an ultimate completion date of July 11, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of VALTOCO 10 MG NASAL SPRAYS to the Defense Logistics Agency (DLA). The contract, awarded to prime contractor Amerisourcebergen Drug Corp, has a ceiling value of $2,274.92 and runs through January 15, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award is for the delivery of VALTOCO 10 MG NASAL SPRAYS to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 10, 2024, with a ceiling value of $1,184.97 and an ultimate completion date of December 11, 2024. The contract is a Delivery Order under a larger Indefinite Delivery...
This federal contract award is for the delivery of VALTOCO 15 MG NASAL SPRAYS to the Defense Logistics Agency (DLA), a defense agency. The $1,671.52 Firm Fixed Price Delivery Order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 6, 2024 with a completion date of November 7, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of VALTOCO 15 MG NASAL SPRAYS to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $1,671.52 and is a firm fixed price delivery order that runs through June 2024. The contract was awarded on a full and open competition basis with no set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award is for the delivery of VALTOCO 10 MG NASAL SPRAYS to the Defense Logistics Agency (DLA). The contract, valued at $8,443.37, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through April 15, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of VALTOCO 10 MG NASAL SPRAYS to the agency. The $9,332.20 firm fixed-price contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of March 15, 2023 and does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA29W
    Delivery Order

This federal contract award is for the delivery of VALTOCO 15 MG NASAL SPRAYS to the Defense Logistics Agency (DLA). The contract, valued at $2,305.39, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC enables the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:15 PM